Retrieve available abstracts of 28 articles: HTML format
Single Articles
April 2025
WOUTERS VM, Helderman RFCPA, Cameron K, van der Hooff SR, et al CDX2 downregulation regulates intrinsic WNT pathway activation, dictating
metastasis in APC and CTNNB1 wildtype colorectal cancer.
Oncogene. 2025 Apr 6. doi: 10.1038/s41388-025-03365. PubMedAbstract available
March 2025
TAIRA A, Aavikko M, Katainen R, Kaasinen E, et al Comprehensive metabolomic and epigenomic characterization of microsatellite
stable BRAF-mutated colorectal cancer.
Oncogene. 2025 Mar 18. doi: 10.1038/s41388-025-03326. PubMedAbstract available
WANG B, Zhang S, Guo Y, Gao W, et al CBX2 as a therapeutic target in colorectal cancer: insights into the altered
chromatin accessibility via RUNX1-CBX2-MAP4K1 axis.
Oncogene. 2025 Mar 13. doi: 10.1038/s41388-025-03331. PubMedAbstract available
February 2025
SHENG Z, Luo S, Huang L, Deng YN, et al SENP1-mediated deSUMOylation of YBX1 promotes colorectal cancer development
through the SENP1-YBX1-AKT signaling axis.
Oncogene. 2025 Feb 23. doi: 10.1038/s41388-025-03302. PubMedAbstract available
YAN Z, He L, Yuan J, Niu Y, et al The splicing factor SRRM2 modulates two S6K kinases to promote colorectal cancer
growth.
Oncogene. 2025 Feb 16. doi: 10.1038/s41388-025-03307. PubMedAbstract available
ZHANG J, Zhai J, Wong CC, Chen H, et al Correction: A novel amplification gene PCI domain containing 2 (PCID2) promotes
colorectal cancer through directly degrading a tumor suppressor promyelocytic
leukemia (PML).
Oncogene. 2025 Feb 12. doi: 10.1038/s41388-025-03304. PubMed
RUAN DY, Li T, Wang YN, Meng Q, et al Correction: FTO downregulation mediated by hypoxia facilitates colorectal cancer
metastasis.
Oncogene. 2025 Feb 4. doi: 10.1038/s41388-025-03287. PubMed
January 2025
REISSLAND M, Hartmann O, Tauch S, Bugter JM, et al Correction: USP10 drives cancer stemness and enables super-competitor signalling
in colorectal cancer.
Oncogene. 2025 Jan 22. doi: 10.1038/s41388-024-03262. PubMed
December 2024
LIAO Y, Yang R, Wang B, Ruan Y, et al Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor
cell-intrinsic interferon response in microsatellite instability colorectal
cancer.
Oncogene. 2024 Dec 26. doi: 10.1038/s41388-024-03255. PubMedAbstract available
November 2024
ZHUANG M, Liu J, Li Y, Zhang J, et al PD-L1 promotes tumor metastasis by regulating the infiltration of FGFBP2(+)Tm
cells in colorectal cancer.
Oncogene. 2024 Nov 18. doi: 10.1038/s41388-024-03223. PubMedAbstract available
WEN M, Qiu Y, Wang M, Tang F, et al Enhancing low-dose radiotherapy efficacy with PARP inhibitors via FBL-mediated
oxidative stress response in colorectal cancer.
Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03207. PubMedAbstract available
DUYSAK T, Kim K, Yun M, Jeong JH, et al Enhanced anti-cancer efficacy of arginine deaminase expressed by tumor-seeking
Salmonella Gallinarum.
Oncogene. 2024;43:3378-3387. PubMedAbstract available
BORDONE R, Ivy DM, D'Amico R, Barba M, et al MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells
through FOXO3a-mediated autophagic adaptation.
Oncogene. 2024;43:3349-3365. PubMedAbstract available
October 2024
BORDING T, Janik T, Bischoff P, Morkel M, et al GPA33 expression in colorectal cancer can be induced by WNT inhibition and
targeted by cellular therapy.
Oncogene. 2024 Oct 29. doi: 10.1038/s41388-024-03200. PubMedAbstract available
REISSLAND M, Hartmann O, Tauch S, Bugter JM, et al USP10 drives cancer stemness and enables super-competitor signalling in
colorectal cancer.
Oncogene. 2024 Oct 23. doi: 10.1038/s41388-024-03141. PubMedAbstract available
LIN W, Xu L, Li Y, Li J, et al Aberrant FAM135B attenuates the efficacy of chemotherapy in colorectal cancer by
modulating SRSF1-mediated alternative splicing.
Oncogene. 2024 Oct 13. doi: 10.1038/s41388-024-03189. PubMedAbstract available
HAN F, Zhou X, Liu L, Yang B, et al GLTSCR1 deficiency promotes colorectal cancer development through regulating
non-homologous end joining.
Oncogene. 2024 Oct 11. doi: 10.1038/s41388-024-03179. PubMedAbstract available
September 2024
XU H, Wang T, Nie H, Sun Q, et al USP36 promotes colorectal cancer progression through inhibition of p53 signaling
pathway via stabilizing RBM28.
Oncogene. 2024 Sep 29. doi: 10.1038/s41388-024-03178. PubMedAbstract available
SUN Z, Dang P, Guo Y, Liu S, et al Targeting CircAURKA prevents colorectal cancer progression via enhancing CTNNB1
protein degradation.
Oncogene. 2024 Sep 28. doi: 10.1038/s41388-024-03155. PubMedAbstract available
TANG W, Yang Y, Fu Z, Xu W, et al The RNA helicase DDX21 activates YAP to promote tumorigenesis and is
transcriptionally upregulated by beta-catenin in colorectal cancer.
Oncogene. 2024 Sep 17. doi: 10.1038/s41388-024-03160. PubMedAbstract available
CHURCHHOUSE AMD, Billard CV, Suzuki T, Pohl SOG, et al Loss of DOCK2 potentiates Inflammatory Bowel Disease-associated colorectal cancer
via immune dysfunction and IFNgamma induction of IDO1 expression.
Oncogene. 2024 Sep 7. doi: 10.1038/s41388-024-03135. PubMedAbstract available
August 2024
GUPTA A, Avadhanula S, Bashyam MD Evaluation of the gene fusion landscape in early onset sporadic rectal cancer
reveals association with chromatin architecture and genome stability.
Oncogene. 2024;43:2449-2462. PubMedAbstract available
July 2024
LI X, Chen Y, Lu R, Hu M, et al Correction: Colorectal cancer cells secreting DKK4 transform fibroblasts to
promote tumour metastasis.
Oncogene. 2024 Jul 15. doi: 10.1038/s41388-024-03101. PubMed
June 2024
GU J, Xu X, Li X, Yue L, et al Tumor-resident microbiota contributes to colorectal cancer liver metastasis by
lactylation and immune modulation.
Oncogene. 2024 Jun 18. doi: 10.1038/s41388-024-03080. PubMedAbstract available
FENG M, Chai C, Hao X, Lai X, et al Inherited KDM6A(A649T) facilitates tumor-immune escape and exacerbates colorectal
signet-ring cell carcinoma outcomes.
Oncogene. 2024;43:1757-1768. PubMedAbstract available
April 2024
CAO N, Zhang F, Yin J, Zhang J, et al LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis.
Oncogene. 2024 Apr 11. doi: 10.1038/s41388-024-02996. PubMedAbstract available
WU Q, Wang Z, Chen S, She X, et al USP26 promotes colorectal cancer tumorigenesis by restraining PRKN-mediated
mitophagy.
Oncogene. 2024 Apr 2. doi: 10.1038/s41388-024-03009. PubMedAbstract available
March 2024
LI X, Chen Y, Lu R, Hu M, et al Colorectal cancer cells secreting DKK4 transform fibroblasts to promote tumour
metastasis.
Oncogene. 2024 Mar 22. doi: 10.1038/s41388-024-03008. PubMedAbstract available